Meiji Holdings Co., Ltd. (TYO:2269)
3,937.00
+327.00 (9.06%)
Aug 6, 2026, 11:30 AM JST
Meiji Holdings Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 1,189,520 | 1,173,688 | 1,154,074 | 1,105,494 | 1,062,157 | 1,013,092 |
Revenue Growth | 3.53% | 1.70% | 4.39% | 4.08% | 4.84% | -14.99% |
Gross Profit Gross Profit Growth | 367,914 | 359,040 | 339,101 | 327,345 | 306,803 | 323,249 |
Operating Income Operating Income Growth | 98,230 | 93,307 | 84,703 | 84,322 | 75,435 | 92,922 |
Net Income Net Income Growth | 40,252 | 35,076 | 50,800 | 50,675 | 69,424 | 87,497 |
Earnings Per Share EPS Growth | 148.49 | 129.42 | 186.08 | 181.64 | 247.38 | 303.62 |
EPS Growth | -14.19% | -30.45% | 2.44% | -26.57% | -18.52% | 34.19% |
| Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Pharmaceuticals Pharmaceuticals Growth | 232,244 | 229,650 | 206,109 | 197,280 | 187,981 |
Unallocated Adjustment Unallocated Adjustment Growth | -1,434 | -1,130 | -742 | -732 | -969 |
Food Food Growth | 942,879 | 925,554 | 900,127 | 865,609 | 826,080 |
Total Total Growth | 1,173,689 | 1,154,074 | 1,105,494 | 1,062,157 | 1,013,092 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 86,348 | 69,249 | 78,191 | 106,858 | 63,519 | 67,409 |
Total Debt Total Debt Growth | 138,265 | 112,584 | 47,799 | 49,926 | 64,370 | 81,266 |
Net Cash (Debt) Net Cash Growth | -51,917 | -43,335 | 30,392 | 56,932 | -851 | -13,857 |
Net Cash Growth | - | - | -46.62% | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -191.52 | -159.90 | 111.33 | 204.07 | -3.03 | -48.09 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 76,394 | 56,522 | 68,979 | 107,983 | 85,013 | 127,526 |
Capital Expenditures CapEx Growth | -97,512 | -96,847 | -52,798 | -50,023 | -68,811 | -88,320 |
Free Cash Flow Free Cash Flow Growth | -21,118 | -40,325 | 16,181 | 57,960 | 16,202 | 39,206 |
Free Cash Flow Growth | - | - | -72.08% | 257.73% | -58.67% | -35.36% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 30.93% | 30.59% | 29.38% | 29.61% | 28.88% | 31.91% |
Operating Margin | 8.26% | 7.95% | 7.34% | 7.63% | 7.10% | 9.17% |
Pretax Margin | 6.13% | 5.80% | 7.15% | 7.92% | 8.98% | 12.68% |
Profit Margin | 3.38% | 2.99% | 4.40% | 4.58% | 6.54% | 8.64% |
FCF Margin | -1.77% | -3.44% | 1.40% | 5.24% | 1.52% | 3.87% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 110.000 | 105.000 | 100.000 | 95.000 | 90.000 | 85.000 |
Dividend Per Share Growth | 4.88% | 5.00% | 5.26% | 5.56% | 5.88% | 6.25% |
Dividend Yield | 3.01% | 2.72% | 3.17% | 2.97% | 3.11% | 2.88% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 27.89 | 29.83 | 17.33 | 18.65 | 12.67 | 10.64 |
Forward PE | 15.13 | 20.71 | 15.89 | 16.85 | 15.63 | 14.02 |
P/FCF Ratio | - | - | 54.41 | 16.31 | 54.29 | 23.74 |
PS Ratio | 0.83 | 0.89 | 0.76 | 0.86 | 0.83 | 0.92 |